Gilead Sciences (GILD) Net Margin (QoQ) (2009 - 2026)
Powered by 
Analysis
Gilead Sciences (GILD) Net Margin (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.76 Bn | 176.58 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.14 Bn | 123.29 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.69 Bn | 73.69 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.39 Bn | 55.20 Bn | 1.37 Bn |
| 6 | Moderna | 53.85 Bn | 48.72 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.14 Bn | 29.84 Bn | 992.69 Mn |
| 8 | Biogen | 31.79 Bn | 30.50 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.02 Bn | 29.02 Bn | 1.16 Mn |
| 10 | Insmed | 27.60 Bn | 26.44 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16,355.00 |
| Mar 31, 2026 | -286.00 |
| Dec 31, 2025 | -739.00 |
| Sep 30, 2025 | 1,159.00 |
| Jun 30, 2025 | 797.00 |
| Mar 31, 2025 | -382.00 |
| Dec 31, 2024 | 694.00 |
| Sep 30, 2024 | -662.00 |
| Jun 30, 2024 | 8,561.00 |
| Mar 31, 2024 | -8,229.00 |
| Dec 31, 2023 | -1,090.00 |
| Sep 30, 2023 | 1,506.00 |
| Jun 30, 2023 | 25.00 |
| Mar 31, 2023 | -661.00 |
| Dec 31, 2022 | -326.00 |
| Sep 30, 2022 | 723.00 |
| Jun 30, 2022 | 1,795.00 |
| Mar 31, 2022 | -501.00 |
| Dec 31, 2021 | -2,966.00 |
| Sep 30, 2021 | 1,045.00 |